Assessment and Care of Oral Lesions for Patients Who Undergo Radioiodine Treatment for Thyroid Cancer


      Patients with differentiated thyroid cancer who undergo radioiodine treatment often present oral complications with a significant impact on their oral cavity function. Any potential sources of systemic infections like periodontal disease, unfitted dentures, orthodontic appliances, deficient/rough fillings, or traumatic dentition must be treated by the dental practitioner, because they represent the main source of spread and dissemination. Any systemic complication of a dental foci may result from improper dental preparation of the patient before radioiodine therapy and inadequate post-radioiodine therapy oral care. Therefore, all patients proceeding into radioiodine treatment should be addressed by the oncological team to undergo thorough dental check-up and receive appropriate treatment in due time.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Siegel R.
        • Miller K.
        • Jemal A
        Cancer statistics, 2015.
        CA Cancer J Clin. 2015; 65: 29
      1. IARC. Globocan 2012. Http://Www-DepIarcFr/. 2016;GLOBOCAN:2012-2013.

        • WHO
        Thyroid Cancer World Health Organization classification.
        2004 (Available at: Accessed August 10, 2020)
        • Tirrò E.
        • Martorana F.
        • Romano C.
        • et al.
        Molecular alterations in thyroid cancer: from bench to clinical practice.
        Genes (Basel). 2019; 10
        • Pacini F.
        • Schlumberger M.
        • Dralle H.
        • et al.
        European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
        Eur J Endocrinol. 2006; 154: 787-803
        • Piciu D.
        • Irimie A.
        • Piciu A
        Investigation of thyroid carcinoma over 40 years, using the database of the ion chiricuta institute of oncology Cluj-Napoca.
        J BUON. 2014; 19: 524-529
        • Piciu D
        Thyroid cancer incidence 25 years after Chernobyl, in a Romanian cancer center: is it a public health problem?.
        Curr Radiopharm. 2013; 6: 249-252
        • Muntean V.
        • Domsa I.
        • Zolog A.
        • et al.
        Incidental papillary thyroid microcarcinoma: is completion surgery required.
        Chirurgia (Bucur). 2013; 108: 490-497
        • Mandel S.J.
        • Mandel L.
        Radioactive iodine and the salivary glands.
        Thyroid. 2003; 13: 265-271
        • Almeida J.P.
        • Kowalski L.P
        Pilocarpina no tratamento de xerostomia em pacientes submetidos à iodoterapia: estudo piloto.
        Braz J Otorhinolaryngol. 2010; 76 (Available at: Accessed August 10, 2020): 659-662
        • Lee H.N.
        • An J.Y.
        • Lee K.M.
        • Kim E.J.
        • Choi W.S.
        • Kim D.Y
        Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.
        Clin Imaging. 2015; 39: 396-400
        • Hovan A.J.
        • Williams P.M.
        • Stevenson-Moore P.
        • et al.
        A systematic review of dysgeusia induced by cancer therapies.
        Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2010; 18: 1081-1087
        • Jonklaas J
        Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.
        Thyroid. 2014; 24: 1806-1814
        • Lee S.L.
        Complications of radioactive iodine treatment of thyroid carcinoma.
        J Natl Compr Canc Netw. 2010; 8 (quiz 1287): 1277-1286
        • Badam R.K.
        • Suram J.
        • Babu D.B.G.
        • et al.
        Assessment of salivary gland function using salivary scintigraphy in pre and post radioactive iodine therapy in diagnosed thyroid carcinoma patients.
        J Clin Diagn Res. 2016; 10 (ZC60-2)
        • Rodrigues M.
        • Havlik E.
        • Peskar B.
        • Sinzinger H
        Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?.
        Eur J Nucl Med. 1998; 25: 265-269
        • Epstein J.B.
        • Beier Jensen S
        Management of hyposalivation and xerostomia: criteria for treatment strategies.
        Compend Contin Educ Dent. 2015; 36: 600-603
        • Wainwright W.W.
        • Butt B.G.
        • Hauptfuehrer J.D.
        • Dute H.L
        Deposition of radioactive iodine in teeth of persons treated for disease of the thyroid gland.
        J Am Dent Assoc. 1953; 47: 649-655
        • Burlison J.S.
        • Hartshorne M.F.
        • Voda A.M.
        • Cocks F.H.
        • Fair J.R
        SPECT/CT localization of oral radioiodine activity: a retrospective study and in-vitro assessment.
        Nucl Med Commun. 2013; 34: 1216-1222
        • Fard-Esfahani A.
        • Emami-Ardekani A.
        • Fallahi B.
        • et al.
        Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma.
        Nucl Med Commun. 2014; 35: 808-817
        • Daniel F.I.
        • Lima L.D.
        • Grando L.J.
        • Castro R.
        • Cordeiro E.A.K.
        • Dos Santos C.R
        Salivary evaluation in radioactive I(131) treated patients with thyroid carcinoma.
        Acta Odontol Scand. 2018; 76: 148-152
        • Aframian D.J.
        • Nahlieli O.
        • Knopf A.
        • Lukach L.
        • Qawasmeh N.
        • Nadler C
        Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
        Quintessence Int. 2013; 44: 439-444
        • Elad S.
        • Raber-Durlacher J.E.
        • Brennan M.T.
        • et al.
        Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the multinational association of supportive care in cancer/international society of oral oncology (MASCC.
        Support Care Cancer. 2015; 23: 223-236
        • Hong C.H.L.
        • Napenas J.J.
        • Hodgson B.D.
        • et al.
        A systematic review of dental disease in patients undergoing cancer therapy.
        Support Care Cancer. 2010; 18: 1007-1021
        • Boguslawska-Kapala A.
        • Halaburda K.
        • Rusyan E.
        • Golabek H.
        • Struzycka I
        Oral health of adult patients undergoing hematopoietic cell transplantation. Pre-transplant assessment and care.
        Ann Hematol. 2017; 96: 1135-1145
      2. MD R., Sandow P., Mendenhall W., MD M. Management of xerostomia, taste impairment and dental prophlaxis. In:; 2005:281–283. doi:10.1007/0-387-25714-4_36

        • Walter M.A.
        • Turtschi C.P.
        • Schindler C.
        • Minnig P.
        • Muller-Brand J.
        • Muller B
        The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study.
        J Nucl Med. 2007; 48: 1620-1625
        • Rosales AC de MN
        • Esteves S.C.B.
        • Jorge J.
        • Almeida OP de
        • Lopes M.A
        Dental needs in Brazilian patients subjected to head and neck radiotherapy.
        Braz Dent J. 2009; 20: 74-77
        • Irie M.-.S.
        • Mendes E.-.M.
        • Borges J.-.S.
        • Osuna L-G-G
        • Rabelo G.-.D.
        • Soares P.-.B.-.F
        Periodontal therapy for patients before and after radiotherapy: a review of the literature and topics of interest for clinicians.
        Med Oral Patol Oral Cir Bucal. 2018; 23: e524-e530
        • Malmberg L.
        • Bjorkner A.E.
        • Bergenholtz G
        Establishment and maintenance of asepsis in endodontics - a review of the Literature.
        Acta Odontol Scand. 2016; 74: 431-435
        • Zero D.T
        Dentifrices, mouthwashes, and remineralization/caries arrestment strategies.
        BMC Oral Health. 2006; 6: S9
      3. Professionally applied topical fluoride: evidence-based clinical recommendations.
        J Am Dent Assoc. 2006; 137: 1151-1159
        • Busaidy N.L.
        • Cabanillas M.E
        Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.
        J Thyroid Res. 2012; 2012618985
        • Sisson J.C.
        • Freitas J.
        • McDougall I.R.
        • et al.
        Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
        Thyroid. 2011; 21: 335-346
        • Gomes-Lima C.J.
        • Wu D.
        • Kharazi P.H.
        • et al.
        Selected radiation safety aspects including transportation and lodging after outpatient (131)I therapy for differentiated thyroid cancer.
        Thyroid. 2017; 27: 1558-1565